Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has had discussions with NICE on the potential merits of innovative brain cancer treatments in Germany that are not currently available on the NHS.

My Rt Hon. Friend, the Secretary of State for Health and Social Care, has had no discussions with the National Institute for Health and Care Excellence (NICE) on the potential merits of innovative brain cancer treatments in Germany that are not currently available on the National Health Service.

In England, NICE makes recommendations for the NHS on whether new licensed medicines should be routinely funded by the NHS based on an assessment of clinical and cost effectiveness. The NHS is legally required to fund NICE recommended medicines, normally within three months of final guidance, and cancer medicines are eligible for funding from the point of a positive draft NICE recommendation. NICE aims wherever possible to issue guidance on new medicines close to the time of licensing to ensure that patients are able to benefit from rapid access to clinically and cost effective new medicines.